ND-654

CAT: 0804-HY-127108Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-127108Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
ND-654 is a highly selective acetyl-CoA carboxylase (ACC) inhibitor (IC50: ACC1=3 nM, ACC2=8 nM) . ND-654 reduces hepatic lipogenesis, decreases neutrophil recruitment and promotes anti-inflammatory M2 macrophage polarization. ND-654 is promising for research of nonalcoholic steatohepatitis and hepatocellular carcinoma[1].
CAS Number
[1434641-55-0]
UNSPSC
12352005
Target
Acetyl-CoA Carboxylase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer; Metabolic Disease
Smiles
CC(C)(N(C(N(C[C@H](O[C@H]1CC[C@@H](O)CC1)C2=CC=CC=C2OC)C3=C4C(C)=C(C5=NC=CO5)S3)=O)C4=O)C(O)=O
Molecular Formula
C29H33N3O8S
Molecular Weight
583.65
References & Citations
[1]Lally JSV, et al. Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma. Cell Metab. 2019 Jan 8;29 (1) :174-182.e5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-161449JTT-654
HY-120041ND-2158
HY-124341ND-378
HY-124373-01ND-336
HY-117622ND-2110
HY-101842-01ND-646
HY-155107-01ND-011992
HY-162588MC-ND-18
HY-124939-01ND-322 (hydrochloride)
HY-124373A(R) -ND-336

Alternative Products

CatalogName
MBS5813203ND-654
A135120Pexelizumab Biosimilar (Monoclonal, scFv-nd-nd)
A135334MOR101 Biosimilar (Monoclonal, Fab-nd-nd)
MBS3612012-01ND-646
MBS5777839ND-2158
BA1520-25ND-011992
MF-0138378-01ND-2110
MF-0143369-01ND-7001
B2248-5ND-630
569838-01ND-75

Popular Products